PXH News and Press, Invesco FTSE RAFI Emerging Markets From 02/02/24

Pixium Vision announces the rejection of the sale plan ( plan de cession ) by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 202 4 – 02:00 p.m. (CET) – Pixium Vision SA (Eu...

Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings to January 31, 2024 Paris, France, January 17, 202 4 – 5:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris...

Postponement of the decision on the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings Paris, France, January 17, 202 4 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mne...

2024-01-16 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-20 09:46:43 ET More on Invesco FTSE RAFI Emerging Markets Portfolio ETF Seeking Alpha’s Quant Rating on Invesco FTSE RAFI Emerging Markets Portfolio ETF Dividend scorecard for Invesco FTSE RAFI Emerging Markets Portfolio ETF For further details see: ...

Decision concerning the adoption of a sale plan ( plan de cession ) and the opening of judicial liquidation proceedings scheduled for January 16, 2024 Paris, France, December 18, 202 3 – 7:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris...

Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023 Paris, France, December 4, 202 3 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovativ...

Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Paris, France, November 20, 202 3 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics compa...

2023-11-16 17:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming 36-month results Patients suffering from central vision loss reliably re...